RMDM launches an early cancer detection screening program using PanTum Detect in Dubai.

RMDM, a stakeholder in Doctor’s Center Polyclinic, is joining forces with the polyclinic to introduce an early detection program.

This partnership aims to leverage their combined resources and expertise to enhance early diagnosis, revolutionizing the landscape of preventive healthcare.

PanTum Detect: A blood test for the early detection of tumour types

PanTum Detect is a pioneering screening test that can filter asymptomatic healthy individuals by screening for the presence of silently growing benign, premalignant or malignant tumours.

Safe, proven and reliable, PanTum Detect is made possible by the innovative EDIM (Epitope Detection in Macrophages) technology Dr Coy and his team developed.

EDIM draws upon the natural mechanism of the immune system to detect universal biomarkers Apo10 and TKTL1 – one of which is detectable in all phases of tumour genesis ( Apo10 ) .

These two genes have been pivotal in developing EDIM technology. Apo10 presents with the earliest signs of tumour development, whilst TKTL1 manifests at the early signs of tumour malignancy andmetastasis. The TKTL1 biomarker was discovered and patented by Dr Coy.

Early cancer diagnosis

With over 200 different types of cancer, recent research data published by Cancer Research UK shows that 1 in 2 people in the UK will get cancer in their lifetime.

PanTum Detect can provide early cancer diagnosis, giving people enough time to make positive and impactful lifestyle changes.

Detecting tumours before they evolve and spread into life-threatening cancers gives time for targeted medical intervention at an early stage, increasing survival rates and preventing relapses. Explore some of the most commonly asked questions.

Screening Program: PanTum Detect + PET/CT

PanTum Detect provides a very high test accuracy (sensitivity of 97.5% and a specificity of 99%), meaning that missed tumours and false positives are highly unlikely. In addition, it is a quick and simple, non-invasive process that is affordable, allowing for regular, annual testing. The screening program combines PanTum Detect with an MRI, PET/CT scan and physician consultation, which allows for safe cancer screening by filtering out non-cancer suspicious patients.

Most potentially dangerous tumours are able to be detected at a very early stage using imaging methods (such as MRI, PET/CT, etc.). However, due to the high costs and radiation exposure (e.g. PET/CT), these procedures are not suitable for use without tumour-suspicion. This convenient blood test combined with imaging empowers us all to detect cancer early, increasing the success rate of cancer treatment. With this technology, we can replace fear with a simple step to healthier lives.

Innovative Technology | Diverse Areas of Application

With further studies and tests planned, our technology will have a wide range of clinical applications. In-depth research is already underway into the therapeutic benefits of our work in areas as varied as Alzheimer’s, dementia and diabetes.

To read the research that underpins EDIM technology and the PanTum Detect test, please visit our Research & Publications section or contact us.

High Specificity High Sensitivity Non-Invasive Quick and Simple Process Affordable

The Doctor’s Center Cancer Screening Program for Early Detection.

Bringing revolutionary early cancer screening to the UAE
Local and easily accessible to the MENA region

Cancer is the third leading cause of death in the United Arab Emirates (UAE) after cardiovascular diseases and trauma.

  • Recent studies show cancer rates are rising in the UAE. Approximately 4,807 new cancer cases were reported in 2020 in the UAE alone (International Agency for Research on Cancer, WHO)
  • Research compiled in the Emirates revealed 45.4% of all cancer diagnoses in 2017 – the most recent figures available – were in people aged between 20 and 49, up from 42.3% two years earlier.
  • The percentage of all cancer cases is significantly higher than in the same age groups in the UK, US, Canada, China and India.

The Screening Program is for the early detection of a wide range of potentially dangerous tumors, i.e. cancer and precancerous lesions.

The program combines the strengths of modern imaging with an innovative blood test: PanTum Detect.

Two blood vials and protective eyewear on a sterile, medical surface

Who Is It For?

For any healthy individuals who:

  • ZHave a family history of cancer.
  • ZDo not want to wait until it might be too late.
  • ZWant to be proactive in maintaining their health.

To book an appointment or learn more about our screening program, please contact our partners at Doctor’s Center Polyclinic.

Other Resources You Might Find Useful